Search

Search Constraints

You searched for: Author/Creator Roshal, Mikhail

Search Results

2. A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Issue 14 (6th December 2022)

4. CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience. Issue 2 (16th February 2022)

5. Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications. Issue 2 (28th January 2020)

6. Comparison of MALDI‐TOF mass spectrometry analysis of peripheral blood and bone marrow‐based flow cytometry for tracking measurable residual disease in patients with multiple myeloma. (5th February 2020)

8. Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial. Issue 6 (June 2021)

9. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma. (June 2020)

10. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations. Issue 11 (26th September 2018)